NCT02354781: A trial that was reported late by Jerry R. Mendell
This trial has reported, although it was 420 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02354781 |
|---|---|
| Title | Phase I/II Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2015 |
| Completion date | Nov. 30, 2017 |
| Required reporting date | Nov. 30, 2018, midnight |
| Actual reporting date | Jan. 24, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 420 |